Alerus Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.44K Hold
22
﹤0.01% 406
2025
Q4
$7.71K Sell
22
-39
-64% -$13.2K ﹤0.01% 369
2025
Q3
$19.7K Hold
61
﹤0.01% 322
2025
Q2
$23.7K Buy
+61
New +$24.5K ﹤0.01% 294
2024
Q3
Sell
-520
Closed -$282K 160
2024
Q2
$282K Sell
520
-10
-2% -$5.29K 0.02% 143
2024
Q1
$275K Sell
530
-47
-8% -$23.4K 0.02% 142
2023
Q4
$272K Sell
577
-270
-32% -$125K 0.02% 135
2023
Q3
$369K Sell
847
-15,120
-95% -$6.86M 0.03% 122
2023
Q2
$7.09M Buy
15,967
+127
+0.8% +$58.6K 0.6% 48
2023
Q1
$7.28M Sell
15,840
-12,428
-44% -$5.91M 0.65% 38
2022
Q4
$14.5M Buy
28,268
+20,544
+266% +$10.4M 1.33% 12
2022
Q3
$3.51M Buy
7,724
+499
+7% +$239K 0.35% 80
2022
Q2
$3.49M Buy
+7,225
New +$3.57M 0.32% 73
2020
Q2
Sell
-3,088
Closed -$701K 161
2020
Q1
$701K Buy
3,088
+265
+9% +$72.2K 0.1% 112
2019
Q4
$853K Buy
+2,823
New +$777K 0.1% 112

Other funds holding ELV

Alerus Financial's ELV Position: Q1 2026 in Review

Alerus Financial held its Elevance Health (ELV) position steady in Q1 2026 at 22 shares worth $6.44K. The position accounts for ﹤0.01% of the portfolio, ranked #406.

Alerus Financial first reported a position in ELV in Q4 2019 and has held it in 15 quarters since. The position peaked at $14.5M in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Alerus Financial held 22 shares of Elevance Health worth $6.44K as of Q1 2026.
  • Alerus Financial left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up ﹤0.01% of Alerus Financial's portfolio in Q1 2026, its #406 holding.
  • Alerus Financial first reported a position in Elevance Health in Q4 2019 and has held it in 15 quarters since.
  • Alerus Financial's Elevance Health position peaked at $14.5M in Q4 2022.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Alerus Financial's 13F filing for Q1 2026, filed 12 May 2026.